Cover Image
市場調查報告書

全球鼻腔給藥市場

Global Intranasal Drug Delivery Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 310405
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
全球鼻腔給藥市場 Global Intranasal Drug Delivery Market 2014-2018
出版日期: 2014年08月13日 內容資訊: 英文 70 Pages
簡介

鼻腔給藥是可不使用針而施予藥物的方法而受到注目。該技術,提供需要長期性治療的病人簡便的藥物投藥方法,對提高患者的QOL(生活品質)很有幫助。從2013年到2018年的全球鼻腔給藥市場,預計以2.92%的年複合成長率擴大。

本報告提供全球鼻腔給藥市場現狀與今後的成長預測、各產品、地區的市場趨勢、市場成長因素及課題、主要供應商的資訊等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
    • 市場規模與預測
  • 波特的五力分析

第7章 各產品的市場區隔

  • 全球各產品鼻腔給藥市場

第8章 地理區分

  • 全球各地區鼻腔給藥市場
  • 南北美洲的鼻腔給藥市場
  • 歐洲、中東、非洲地區的鼻腔給藥市場
  • 亞太地區的鼻腔給藥市場

第9章 購買標準

第10章 市場成長因素

第11章 成長因素與其影響

第12章 市場課題

第13章 成長因素與課題的影響

第14章 市場趨勢

第15章 趨勢與其影響

第16章 業者情勢

  • 競爭模式
    • 主要消息
  • 市場佔有率分析
  • 其他卓越供應商

第17章 主要供應商分析

  • Becton, Dickinson and Co.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Novartis AG
目錄
Product Code: IRTNTR3932

About Intranasal Drug Delivery

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.

TechNavio's analysts forecast the Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:

  • Nasal spray
  • Nasal drop
  • Nasal powder
  • Nasal gel
  • Nasal vaccine

TechNavio's report, the Global Intranasal Drug Delivery market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intranasal Drug Delivery market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Becton, Dickinson and Company
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis

Other Prominent Vendors

  • Actiza Pharmaceutical
  • Aptar Group
  • Korten Pharmaceuticals
  • OptiNose
  • Patheon
  • Vee Remedies
  • Zymeth Wellness

Market Driver

  • Increase in Aging Population

For a full, detailed list, view our report

Market Challenge

  • Risk of Over Dosage and Side Effects

For a full, detailed list, view our report

Market Trend

  • Increased Adoption of Non-invasive Products

For a full, detailed list, view our report

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
    • 06.1.1. Market Size and Forecast
  • 06.2. Five Forces Analysis

07. Market Segmentation by Product

  • 07.1. Global Intranasal Drug Delivery market by Product 2013-2018

08. Geographical Segmentation

  • 08.1. Global Intranasal Drug Delivery Market by Geographical Segmentation 2013-2018
    • 08.1.1. Market Size and Forecast
  • 08.2. Intranasal Drug Delivery Market in the Americas
    • 08.2.1. Market Size and Forecast
  • 08.3. Intranasal Drug Delivery Market in the EMEA Region
    • 08.3.1. Market Size and Forecast
  • 08.4. Intranasal Drug Delivery Market in the APAC Region
    • 08.4.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Becton, Dickinson and Co.
    • 17.1.1. Key Facts
    • 17.1.2
    • 17.1.3. Business Description
    • 17.1.4. Business Segmentation
    • 17.1.5. Revenue Segmentation by Business
    • 17.1.6. Segmental Revenue Comparison - 2013 and 2012
    • 17.1.7. Revenue Segmentation by Geography
    • 17.1.8. Business Strategy
    • 17.1.9. Key Developments
  • 17.2. SWOT Analysis
    • 17.2.1. SWOT Overview
    • 17.2.2. Strengths
    • 17.2.3. Weakness
    • 17.2.4. Opportunities
    • 17.2.5. Threats
  • 17.3. GlaxoSmithKline plc
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Business Segmentation
    • 17.3.4. Business Segmentation by Revenue 2012 and 2013
    • 17.3.5. Sales by Geography
    • 17.3.6. Pipeline Products
    • 17.3.7. Business Strategy
    • 17.3.8. Key Information
    • 17.3.9. SWOT Analysis
    • 17.3.10. Strengths
    • 17.3.11. Weaknesses
    • 17.3.12. Opportunities
    • 17.3.13. Threats
  • 17.4. Johnson & Johnson
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation by Revenue 2013
    • 17.4.4. Business Segmentation by Revenue 2012 and 2013
    • 17.4.5. Geographical Segmentation by Revenue 2013
    • 17.4.6. Business Strategy
    • 17.4.7. Recent Developments
    • 17.4.8. SWOT Analysis
    • 17.4.9. Strengths
    • 17.4.10. Weaknesses
    • 17.4.11. Opportunities
    • 17.4.12. Threats
  • 17.5. Novartis AG
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation by Revenue 2013
    • 17.5.4. Business Segmentation by Revenue 2012 and 2013
    • 17.5.5. Sales by Geography
    • 17.5.6. Business Strategy
    • 17.5.7. Key Developments
  • 17.6. SWOT Analysis
    • 17.6.1. Strengths
    • 17.6.2. Weaknesses
    • 17.6.3. Opportunities
    • 17.6.4. Threats

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Intranasal Drug Delivery Market 2013-2018 (US$ million)
  • Exhibit 3: Global Intranasal Drug Delivery Market Segmentation by Product Type
  • Exhibit 4: Global Intranasal Drug Delivery Market by Geographical Segmentation 2013
  • Exhibit 5: Global Intranasal Drug Delivery Market by Geographical Segmentation 2013-2018
  • Exhibit 6: Intranasal Drug Delivery Market in the Americas Region 2013-2018 (US$ million)
  • Exhibit 7: Intranasal Drug Delivery Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 8: Intranasal Drug Delivery Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 9: Product Categorization of Becton, Dickinson and Co.
  • Exhibit 10: Revenue Segmentation of Becton, Dickinson and Co. 2013
  • Exhibit 11: Revenue Comparison (US$ million)
  • Exhibit 12: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
  • Exhibit 13: GlaxoSmithKline plc: Business Segmentation 2013
  • Exhibit 14: GlaxoSmithKline plc: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 15: GlaxoSmithKline plc: Sales by Geography 2013
  • Exhibit 16: GlaxoSmithKline plc: Pipeline Products 2013
  • Exhibit 17: Johnson & Johnson: Business Segmentation by Revenue 2013
  • Exhibit 18: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 19: Johnson & Johnson: Geographical Segmentation by Revenue 2013
  • Exhibit 20: Novartis AG: Business Segmentation by Revenue 2013
  • Exhibit 21: Novartis AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 22: Novartis AG: Sales by Geography 2013
Back to Top